246 related articles for article (PubMed ID: 21778271)
21. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
[TBL] [Abstract][Full Text] [Related]
22. Suppression of experimental autoimmune uveoretinitis by regulatory dendritic cells in mice.
Usui Y; Takeuchi M; Hattori T; Okunuki Y; Nagasawa K; Kezuka T; Okumura K; Yagita H; Akiba H; Goto H
Arch Ophthalmol; 2009 Apr; 127(4):514-9. PubMed ID: 19365033
[TBL] [Abstract][Full Text] [Related]
23. SOCS1 Mimetic Peptide Suppresses Chronic Intraocular Inflammatory Disease (Uveitis).
He C; Yu CR; Mattapallil MJ; Sun L; Larkin Iii J; Egwuagu CE
Mediators Inflamm; 2016; 2016():2939370. PubMed ID: 27703302
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of inducible co-stimulator (ICOS) by intravitreal injection of small interfering RNA (siRNA) plasmid suppresses ongoing experimental autoimmune uveoretinitis in rats.
Hou Y; Xing L; Fu S; Zhang X; Liu J; Liu H; Lv B; Cui H
Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):755-65. PubMed ID: 19125271
[TBL] [Abstract][Full Text] [Related]
25. CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo.
Siepmann K; Biester S; Plsková J; Muckersie E; Duncan L; Forrester JV
Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):221-9. PubMed ID: 16741709
[TBL] [Abstract][Full Text] [Related]
26. Suramin treatment suppresses induction of experimental autoimmune uveoretinitis (EAU) in rodents.
Sartani G; Silver PB; Strassmann G; Chan CC; Caspi RR
Curr Eye Res; 1995 Oct; 14(10):887-96. PubMed ID: 8549154
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene.
De Kozak Y; Thillaye-Goldenberg B; Naud MC; Da Costa AV; Auriault C; Verwaerde C
Clin Exp Immunol; 2002 Nov; 130(2):212-23. PubMed ID: 12390308
[TBL] [Abstract][Full Text] [Related]
28. Suppression of established experimental autoimmune uveitis by anti-LFA-1alpha Ab.
Ke Y; Sun D; Zhang P; Jiang G; Kaplan HJ; Shao H
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2667-75. PubMed ID: 17525198
[TBL] [Abstract][Full Text] [Related]
29. SOCS3 deletion in T lymphocytes suppresses development of chronic ocular inflammation via upregulation of CTLA-4 and expansion of regulatory T cells.
Yu CR; Kim SH; Mahdi RM; Egwuagu CE
J Immunol; 2013 Nov; 191(10):5036-43. PubMed ID: 24101549
[TBL] [Abstract][Full Text] [Related]
30. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
Haq E; Rohrer B; Nath N; Crosson CE; Singh I
J Ocul Pharmacol Ther; 2007 Jun; 23(3):221-31. PubMed ID: 17593005
[TBL] [Abstract][Full Text] [Related]
31. Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): potential neuroprotective role of SOCS proteins.
Takase H; Yu CR; Liu X; Fujimoto C; Gery I; Egwuagu CE
J Neuroimmunol; 2005 Nov; 168(1-2):118-27. PubMed ID: 16154209
[TBL] [Abstract][Full Text] [Related]
32. Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10.
Lee YS; Amadi-Obi A; Yu CR; Egwuagu CE
Immunology; 2011 Apr; 132(4):492-502. PubMed ID: 21294722
[TBL] [Abstract][Full Text] [Related]
33. Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B Inhibitor dehydroxy methyl epoxyquinomicin in mice.
Iwata D; Kitaichi N; Miyazaki A; Iwabuchi K; Yoshida K; Namba K; Ozaki M; Ohno S; Umezawa K; Yamashita K; Todo S; Ishida S; Onoé K
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2077-84. PubMed ID: 19907030
[TBL] [Abstract][Full Text] [Related]
34. Oral administration of interferon-beta suppresses experimental autoimmune uveoretinitis.
Suzuki J; Sakai J; Okada AA; Takada E; Usui M; Mizuguchi J
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):314-21. PubMed ID: 11981647
[TBL] [Abstract][Full Text] [Related]
35. Protective effect of intravitreal administration of tresperimus, an immunosuppressive drug, on experimental autoimmune uveoretinitis.
Bousquet E; Camelo S; Leroux les Jardins G; Goldenberg B; Naud MC; Besson-Lescure B; Lebreton L; Annat J; Behar-Cohen F; de Kozak Y
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5414-23. PubMed ID: 21666239
[TBL] [Abstract][Full Text] [Related]
36. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
[TBL] [Abstract][Full Text] [Related]
37. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
Keino H; Kezuka T; Takeuchi M; Yamakawa N; Hattori T; Usui M
Arch Ophthalmol; 2004 Aug; 122(8):1179-84. PubMed ID: 15302659
[TBL] [Abstract][Full Text] [Related]
38. Caffeic acid phenethyl ester lessens disease symptoms in an experimental autoimmune uveoretinitis mouse model.
Choi JH; Roh KH; Oh H; Park SJ; Ha SM; Kang MS; Lee JH; Jung SY; Song H; Yang JW; Park S
Exp Eye Res; 2015 May; 134():53-62. PubMed ID: 25795054
[TBL] [Abstract][Full Text] [Related]
39. Tgf-beta inhibits activation and uveitogenicity of primary but not of fully polarized retinal antigen-specific memory-effector T cells.
Xu H; Silver PB; Tarrant TK; Chan CC; Caspi RR
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4805-12. PubMed ID: 14578402
[TBL] [Abstract][Full Text] [Related]
40. Reactivation of uveitogenic T cells by retinal astrocytes derived from experimental autoimmune uveitis-prone B10RIII mice.
Jiang G; Ke Y; Sun D; Han G; Kaplan HJ; Shao H
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):282-9. PubMed ID: 18172104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
